...
首页> 外文期刊>Molecular pharmaceutics >Redox- and pH-Sensitive Glycan (Polysialic Acid) Derivatives and F127 Mixed Micelles for Tumor-Targeted Drug Delivery
【24h】

Redox- and pH-Sensitive Glycan (Polysialic Acid) Derivatives and F127 Mixed Micelles for Tumor-Targeted Drug Delivery

机译:氧化还原和pH敏感的聚糖(聚均酸)衍生物和F127混合胶束用于肿瘤靶向药物递送

获取原文
获取原文并翻译 | 示例

摘要

With increasing application of PEGylated products, drawbacks are beginning to emerge such as the "PEG dilemma". Other promising materials may need to be found in the current situation. Endogenous polysialic acid (PSA), which is highly expressed on mammalian, bacterial, and malignant surface, may be a promising material in oncology. In this study, a dual-responsive amphiphilic PSA cholesterol derivative (PSA-CS-CH) was synthesized to explore the opportunity of PSA in targeted drug delivery systems. PSA-CS-CH, F127 mixed micelles (PF-M), and pure F127 micelles (F-M) were prepared for comparative antitumor experiments. The in vitro experiments showed that modification of PSA-CS-CH significantly increased cytotoxicity and cellular uptake. PF-M had excellent tumor microenvironment response release behavior on acidic media with high GSH levels. The in vivo fluorescence imaging and antitumor experiments showed that PF-M had excellent tumor targeting ability and great tumor suppression ability. In summary, biodegradable PSA may contribute to cancer therapy.
机译:随着Pegymated产品的增加,缺点开始出现,例如“PEG困境”。其他有希望的材料可能需要在目前的情况下找到。在哺乳动物,细菌和恶性表面上高度表达的内源性聚甲酸(PSA)可以是肿瘤学中有希望的材料。在该研究中,合成了双响应式两亲性PSA胆固醇衍生物(PSA-CS-CH),以探讨PSA在靶向药物递送系统中的机会。为比较抗肿瘤实验制备PSA-CS-CH,F127混合胶束(PF-M)和纯F127胶束(F-M)。体外实验表明,PSA-CS-CH的修饰显着增加了细胞毒性和细胞摄取。 PF-M具有高GSH水平的酸性介质上具有优异的肿瘤微环境反应释放行为。体内荧光成像和抗肿瘤实验表明,PF-M具有优异的肿瘤靶向能力和大的肿瘤抑制能力。总之,可生物降解的PSA可能有助于癌症治疗。

著录项

  • 来源
    《Molecular pharmaceutics 》 |2018年第12期| 共12页
  • 作者单位

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

    Shenyang Pharmaceut Univ Coll Pharm 103 Wenhua Rd Shenyang 110016 Liaoning Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学 ;
  • 关键词

    polysialic acid; tumor-targeted; dual-responsive; pH-sensitive; drug delivery system;

    机译:聚核酸;肿瘤靶向;双响应;pH敏感;药物递送系统;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号